226 related articles for article (PubMed ID: 1370773)
1. Definition of an immunodominant T cell epitope contained in the envelope gp41 sequence of HIV-1.
Bell SJ; Cooper DA; Kemp BE; Doherty RR; Penny R
Clin Exp Immunol; 1992 Jan; 87(1):37-45. PubMed ID: 1370773
[TBL] [Abstract][Full Text] [Related]
2. B cell epitope mapping of human immunodeficiency virus envelope glycoproteins with long (19- to 36-residue) synthetic peptides.
Neurath AR; Strick N; Lee ES
J Gen Virol; 1990 Jan; 71 ( Pt 1)():85-95. PubMed ID: 1689372
[TBL] [Abstract][Full Text] [Related]
3. Identification of overlapping HLA class I-restricted cytotoxic T cell epitopes in a conserved region of the human immunodeficiency virus type 1 envelope glycoprotein: definition of minimum epitopes and analysis of the effects of sequence variation.
Johnson RP; Trocha A; Buchanan TM; Walker BD
J Exp Med; 1992 Apr; 175(4):961-71. PubMed ID: 1372650
[TBL] [Abstract][Full Text] [Related]
4. Conversion of an immunogenic human immunodeficiency virus (HIV) envelope synthetic peptide to a tolerogen in chimpanzees by the fusogenic domain of HIV gp41 envelope protein.
Haynes BF; Arthur LO; Frost P; Matthews TJ; Langlois AJ; Palker TJ; Hart MK; Scearce RM; Jones DM; McDanal C
J Exp Med; 1993 Mar; 177(3):717-27. PubMed ID: 7679708
[TBL] [Abstract][Full Text] [Related]
5. A synthetic peptide from the first conserved region in the envelope protein gp160 is a strong T-cell epitope in HIV-infected chimpanzees and humans.
Nehete PN; Schapiro SJ; Johnson PC; Murthy KK; Satterfield WC; Sastry KJ
Viral Immunol; 1998; 11(3):147-58. PubMed ID: 9918406
[TBL] [Abstract][Full Text] [Related]
6. [Composition of HIV-1 B-epitopes and heterologous T-cell epitopes. I. Maintenance of antigenic properties of HIV-1 B-epitopes].
Isaguliants MG; Koshida R; Ruden U; Varen B
Biokhimiia; 1996 Jul; 61(7):1221-9. PubMed ID: 9035735
[TBL] [Abstract][Full Text] [Related]
7. Envelope sequence variability and serologic characterization of HIV type 1 group O isolates from equatorial guinea.
Hunt JC; Golden AM; Lund JK; Gürtler LG; Zekeng L; Obiang J; Kaptué L; Hampl H; Vallari A; Devare SG
AIDS Res Hum Retroviruses; 1997 Aug; 13(12):995-1005. PubMed ID: 9264286
[TBL] [Abstract][Full Text] [Related]
8. Analysis of genetic variability within the immunodominant epitopes of envelope gp41 from human immunodeficiency virus type 1 (HIV-1) group M and its impact on HIV-1 antibody detection.
Dorn J; Masciotra S; Yang C; Downing R; Biryahwaho B; Mastro TD; Nkengasong J; Pieniazek D; Rayfield MA; Hu DJ; Lal RB
J Clin Microbiol; 2000 Feb; 38(2):773-80. PubMed ID: 10655384
[TBL] [Abstract][Full Text] [Related]
9. Comprehensive T-cell epitope mapping of HIV-1 env antigens reveals many areas recognized by HIV-1-seropositive and by low-risk HIV-1-seronegative individuals.
Mutch D; Underwood J; Geysen M; Rodda S
J Acquir Immune Defic Syndr (1988); 1994 Sep; 7(9):879-90. PubMed ID: 7519672
[TBL] [Abstract][Full Text] [Related]
10. Antibody responses to HIV-1 envelope and gag epitopes in HIV-1 seroconverters with rapid versus slow disease progression.
Zwart G; van der Hoek L; Valk M; Cornelissen MT; Baan E; Dekker J; Koot M; Kuiken CL; Goudsmit J
Virology; 1994 Jun; 201(2):285-93. PubMed ID: 7514319
[TBL] [Abstract][Full Text] [Related]
11. In vivo induction of human immunodeficiency virus type 1-specific cytotoxic T lymphocytes and delayed-type hypersensitivity by a 23-amino acid peptide from the highly conserved region in major core protein p24.
Nishino Y; Kameoka M; Okada Y; Zhong Q; Kimura T; Azuma I; Ikuta K
Vaccine; 1994 May; 12(6):485-91. PubMed ID: 7913566
[TBL] [Abstract][Full Text] [Related]
12. Vaccination with the Conserved Caveolin-1 Binding Motif in Human Immunodeficiency Virus Type 1 Glycoprotein gp41 Delays the Onset of Viral Infection and Provides Partial Protection in Simian/Human Immunodeficiency Virus-Challenged Cynomolgus Macaques.
Hovanessian AG; Soundaramourty C; Benferhat R; Le Grand R; Dereuddre-Bosquet N; Krust B; Estaquier J
J Virol; 2018 Sep; 92(18):. PubMed ID: 29976675
[TBL] [Abstract][Full Text] [Related]
13. Polyvalent human immunodeficiency virus synthetic immunogen comprised of envelope gp120 T helper cell sites and B cell neutralization epitopes.
Palker TJ; Matthews TJ; Langlois A; Tanner ME; Martin ME; Scearce RM; Kim JE; Berzofsky JA; Bolognesi DP; Haynes BF
J Immunol; 1989 May; 142(10):3612-9. PubMed ID: 2469721
[TBL] [Abstract][Full Text] [Related]
14. Humoral responses to linear epitopes on the HIV-1 envelope in seropositive volunteers after vaccine therapy with rgp160.
Loomis LD; Deal CD; Kersey KS; Burke DS; Redfield RR; Birx DL
J Acquir Immune Defic Syndr Hum Retrovirol; 1995 Sep; 10(1):13-26. PubMed ID: 7544225
[TBL] [Abstract][Full Text] [Related]
15. [Composition of HIV-1 B-epitopes and heterologous T-cell epitopes. II. Combined analysis of immunogenicity of composite peptides in rabbits].
Isaruliants MG; Ruden U; Wahren B
Biokhimiia; 1996 Jul; 61(7):1230-40. PubMed ID: 9035736
[TBL] [Abstract][Full Text] [Related]
16. T cell receptor usage and fine specificity of human immunodeficiency virus 1-specific cytotoxic T lymphocyte clones: analysis of quasispecies recognition reveals a dominant response directed against a minor in vivo variant.
Kalams SA; Johnson RP; Dynan MJ; Hartman KE; Harrer T; Harrer E; Trocha AK; Blattner WA; Buchbinder SP; Walker BD
J Exp Med; 1996 Apr; 183(4):1669-79. PubMed ID: 8666925
[TBL] [Abstract][Full Text] [Related]
17. The immunosuppressive peptide of HIV-1: functional domains and immune response in AIDS patients.
Denner J; Norley S; Kurth R
AIDS; 1994 Aug; 8(8):1063-72. PubMed ID: 7986401
[TBL] [Abstract][Full Text] [Related]
18. The immunosuppressive peptide of HIV-1 inhibits T and B lymphocyte stimulation.
Denner J; Persin C; Vogel T; Haustein D; Norley S; Kurth R
J Acquir Immune Defic Syndr Hum Retrovirol; 1996 Aug; 12(5):442-50. PubMed ID: 8757420
[TBL] [Abstract][Full Text] [Related]
19. Maternal humoral factors associated with perinatal human immunodeficiency virus type-1 transmission in a cohort from Kigali, Rwanda, 1988-1994.
Tranchat C; Van de Perre P; Simonon-Sorel A; Karita E; Benchaïb M; Lepage P; Desgranges C; Boyer V; Trépo C
J Infect; 1999 Nov; 39(3):213-20. PubMed ID: 10714798
[TBL] [Abstract][Full Text] [Related]
20. Immunodominant glycoprotein 41 epitope identified by seroreactivity in HIV type 1-infected individuals.
Calarota S; Jansson M; Levi M; Broliden K; Libonatti O; Wigzell H; Wahren B
AIDS Res Hum Retroviruses; 1996 May; 12(8):705-13. PubMed ID: 8744581
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
